FIGURE 6.
Net interaction effects of paired-BCA treatments in symptom development on immature “Pink Lady” apples. Box-and-whisker plots show the distribution of net interaction values for each strain (on the x-axis) combined with the remaining strains (gray dots). (A,B) Net interactions between strains calculated as the difference between the observed efficacy of the pair, assessed as percent disease severity reduction (%DSR) (A) or percent control efficacy (%CE) (B), and the expected efficacy based on Bliss independence model with overlapping. (C,D) Net interactions between strains calculated as the difference between the observed efficacy of the pair, assessed as percent disease severity reduction (%DSR) (C) or percent control efficacy (%CE) (D), and the highest of the two single-strain efficacies (best single agent criterium). Box plots show the median, interquartile range and range, with points indicating paired-strain net interaction values. The gray area between 5% and –5% indicates neutrality/additivity (no interaction). Different letters indicate statistically significant differences between groups based on post-hoc tests (a = 0.05). Heatmaps illustrate net biocontrol efficacy patterns for each pairwise combination. In the color scale, intense yellow indicates synergy (symptom suppression above the expected), white indicates neutral/additive interactions and black denotes antagonistic interactions effects (observed lesions larger than expected). Microbacterium sp. 2173; Microbacterium sp. ABR10, Priestia sp. ABR6, Curtobacterium sp. ABR8; Bacillus sp. 2175, Bacillus sp. BWC; Rahnella sp. EL51, Erwinia sp. 2186; Pantoea sp. ABR1b, Pantoea sp. ABR1s, Pseudomonas sp. ABR5, Pseudomonas sp. 2180; yeast: Rhodotorula sp. 2176.
